Eric Dobmeier Chinook Therapeutics, Inc. (KDNY) insider trading activity
Eric Dobmeier is President, CEO of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on Dec 09, 2020, when has been sold 2,000 shares (Common Stock) at a price of $13.07 per share, resulting in proceeds of $26,140. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
ERIC DOBMEIER Transaction History
Also insider at
ED
Eric Dobmeier
President, CEO
Seattle, WA